An expensive screening program designed to keep the Zika virus out of the Red Cross’ blood supply has caught fewer than a dozen infected donations, a new study published Wednesday revealed. Study authors include our Jeremy Sugarman

Quick Read

They’re the tech-age version of donor jars at the diner: crowdfunding websites that aim to link ailing people with strangers willing to help pay for medical treatment. But new research suggests duped patients sometimes crowdfund to pay for bogus stem cell treatments.

Quick Read

The cloned animals look alike, but have distinct personalities and demeanors and cloning companies should be upfront about that, ethicists say. “What often is driving the transaction, I think, is that people want it to be a rebirth of their pet,” said Alan Regenberg, with the Johns Hopkins Berman Institute of Bioethics.

Quick Read

Vox’s emergency room database shows that patients can face steep bills even when they decline treatment

Quick Read

A viral video from Baltimore is drawing attention to a crisis that’s unfolding in emergency rooms across the country: Surging numbers of patients with psychiatric conditions aren’t receiving the care they need

Quick Read

Two doses a year of an antibiotic can sharply cut death rates among infants in poor countries, perhaps by as much as 25 percent among the very young, researchers reported on Wednesday

Quick Read

Eye drop users everywhere have had it happen. Tilt your head back, drip a drop in your eye, and part of that drop always seems to dribble down your cheek. But what most people see as an annoyance, some prescription drop users say is grounds for a lawsuit

Quick Read

At first glance, a bill passed by the House of Representatives this week seems like the kind of thing anyone could get behind. It would allow terminally ill patients access to experimental drugs without the approval of the FDA. But the bill and a similar one passed last summer by the Senate do little to address the main barrier that patients face in getting unapproved treatments: permission from the drug companies themselves

Quick Read